all-antibody

Malnutrition-Inflammation Complex Syndrome In Dialysis Patients

Robust affiliation between malnutrition, irritation, and atherosclerosis in power renal failure.

Background

Atheroscleroticcardiovascular illness and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.

METHODS

100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.

Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion. The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.

RESULTS

In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).

 

Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.

 

Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.

all-antibody
all-antibody

CONCLUSIONS

These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.

GPR61 antibody

20R-GR069 50 ug
EUR 656
Description: Rabbit polyclonal GPR61 antibody

GPR61 antibody

20R-GR070 50 ug
EUR 656
Description: Rabbit polyclonal GPR61 antibody

GPR61 Polyclonal Antibody

ES11477-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against GPR61 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPR61 Polyclonal Antibody

ES11477-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against GPR61 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPR61 Polyclonal Antibody

ABP58695-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody

ABP58695-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody

ABP58695-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Conjugated Antibody

C44933 100ul
EUR 397

GPR61 siRNA

20-abx918539
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

GPR61 siRNA

20-abx918540
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

GPR61 Recombinant Protein (Rat)

RP203447 100 ug Ask for price

GPR61 Recombinant Protein (Human)

RP013882 100 ug Ask for price

GPR61 Recombinant Protein (Mouse)

RP139673 100 ug Ask for price

GPR61 cloning plasmid

CSB-CL866330HU-10ug 10ug
EUR 233
Description: A cloning plasmid for the GPR61 gene.

GPR61 Blocking Peptide

DF2755-BP 1mg
EUR 195

GPR61 Blocking Peptide

DF2810-BP 1mg
EUR 195

Polyclonal GPR61 Antibody (C-Terminus)

APR16588G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (C-Terminus)

APR16589G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (Cytoplasmic Domain)

APR16590G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (Extracellular Domain)

APR16591G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (N-Terminus)

APR16592G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (N-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 280

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 280

Human GPR61 shRNA Plasmid

20-abx963213
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Mouse GPR61 shRNA Plasmid

20-abx981729
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody

20-abx147479
  • EUR 425.00
  • EUR 342.00
  • 100 ug
  • 50 ug

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody

abx147480-100ug 100 ug
EUR 439

GPR61 Protein Vector (Human) (pPB-C-His)

PV018509 500 ng
EUR 329

GPR61 Protein Vector (Human) (pPB-N-His)

PV018510 500 ng
EUR 329

GPR61 Protein Vector (Human) (pPM-C-HA)

PV018511 500 ng
EUR 329

GPR61 Protein Vector (Human) (pPM-C-His)

PV018512 500 ng
EUR 329

GPR61 Protein Vector (Rat) (pPB-C-His)

PV271266 500 ng
EUR 603

GPR61 Protein Vector (Rat) (pPB-N-His)

PV271267 500 ng
EUR 603

GPR61 Protein Vector (Rat) (pPM-C-HA)

PV271268 500 ng
EUR 603

GPR61 Protein Vector (Rat) (pPM-C-His)

PV271269 500 ng
EUR 603

GPR61 Protein Vector (Mouse) (pPB-C-His)

PV186234 500 ng
EUR 603

GPR61 Protein Vector (Mouse) (pPB-N-His)

PV186235 500 ng
EUR 603

GPR61 Protein Vector (Mouse) (pPM-C-HA)

PV186236 500 ng
EUR 603

GPR61 Protein Vector (Mouse) (pPM-C-His)

PV186237 500 ng
EUR 603

Gpr61 ORF Vector (Rat) (pORF)

ORF067817 1.0 ug DNA
EUR 506

Gpr61 ORF Vector (Mouse) (pORF)

ORF046559 1.0 ug DNA
EUR 506

GPR61 ORF Vector (Human) (pORF)

ORF004628 1.0 ug DNA
EUR 95

GPR61 sgRNA CRISPR Lentivector set (Human)

K0892201 3 x 1.0 ug
EUR 339

Gpr61 sgRNA CRISPR Lentivector set (Rat)

K6526201 3 x 1.0 ug
EUR 339

Gpr61 sgRNA CRISPR Lentivector set (Mouse)

K3882801 3 x 1.0 ug
EUR 339

GPR61 sgRNA CRISPR Lentivector (Human) (Target 1)

K0892202 1.0 ug DNA
EUR 154

GPR61 sgRNA CRISPR Lentivector (Human) (Target 2)

K0892203 1.0 ug DNA
EUR 154

GPR61 sgRNA CRISPR Lentivector (Human) (Target 3)

K0892204 1.0 ug DNA
EUR 154

Gpr61 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6526202 1.0 ug DNA
EUR 154

Gpr61 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6526203 1.0 ug DNA
EUR 154

Gpr61 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6526204 1.0 ug DNA
EUR 154

GPR61 3'UTR GFP Stable Cell Line

TU059173 1.0 ml
EUR 1521

Gpr61 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3882802 1.0 ug DNA
EUR 154

Gpr61 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3882803 1.0 ug DNA
EUR 154

Gpr61 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3882804 1.0 ug DNA
EUR 154

GPR61 3'UTR Luciferase Stable Cell Line

TU009173 1.0 ml
EUR 1521

Gpr61 3'UTR GFP Stable Cell Line

TU255385 1.0 ml Ask for price

Gpr61 3'UTR Luciferase Stable Cell Line

TU205385 1.0 ml Ask for price

Gpr61 3'UTR GFP Stable Cell Line

TU159034 1.0 ml Ask for price

Gpr61 3'UTR Luciferase Stable Cell Line

TU109034 1.0 ml Ask for price

Human Probable G- protein coupled receptor 61, GPR61 ELISA KIT

ELI-32663h 96 Tests
EUR 824

Mouse Probable G- protein coupled receptor 61, Gpr61 ELISA KIT

ELI-31707m 96 Tests
EUR 865

GPR61 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0892205 3 x 1.0 ug
EUR 376

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6526205 3 x 1.0 ug
EUR 376

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3882805 3 x 1.0 ug
EUR 376

GPR61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0892206 1.0 ug DNA
EUR 167

GPR61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0892207 1.0 ug DNA
EUR 167

GPR61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0892208 1.0 ug DNA
EUR 167

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6526206 1.0 ug DNA
EUR 167

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6526207 1.0 ug DNA
EUR 167

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6526208 1.0 ug DNA
EUR 167

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3882806 1.0 ug DNA
EUR 167

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3882807 1.0 ug DNA
EUR 167

Gpr61 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3882808 1.0 ug DNA
EUR 167

Anti-PML Protein Antibody

PB10084 100ug/vial
EUR 334

Anti-PML Protein Antibody

PB10085 100ug/vial
EUR 334

Anti-Random protein antibody

STJ140013 150 µg
EUR 219
Description: Goat polyclonal antibody to Random recombinant protein fragment. This Random recombinant protein fragment does not have any homology to known protein sequence. This antibody can be used in biochemical and cell biology experiments as a negative control.

Anti-ALK Protein antibody

STJ16100308 1 mL
EUR 1329

Anti-Protein C antibody

STJ96586 200 µl
EUR 197
Description: Rabbit polyclonal to Protein C.

Anti-Protein Z antibody

STJ98340 100 µl
EUR 234
Description: Mouse monoclonal to Protein Z.

Anti-CutA protein antibody

STJ73349 100 µg
EUR 359

Anti-Protein Vestigial Antibody

STJ503515 100 µg
EUR 476

 

Malnutrition-inflammation complicated syndrome in dialysis sufferers: causes and penalties.

BACKGROUND

Atherosclerotic heart problems and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.

 

METHODS

 

100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.

 

Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion.

The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.

RESULTS

In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).

 

Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.

Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.

 

CONCLUSIONS

These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.

  • Protein-energy malnutrition (PEM) and irritation are widespread and often concurrent in upkeep dialysis sufferers. Many components that seem to result in these 2 situations overlap, as do evaluation instruments and such standards for detecting them as hypoalbuminemia.
  • Each these situations are associated to poor dialysis end result. Low urge for food and a hypercatabolic state are amongst widespread options. PEM in dialysis sufferers has been advised to be secondary to irritation; nonetheless, the proof isn’t conclusive, and an equicausal standing and even reverse causal route is feasible.
  • Therefore, malnutrition-inflammation complicated syndrome (MICS) is an applicable time period. Attainable causes of MICS embody comorbid diseases, oxidative and carbonyl stress, nutrient loss by means of dialysis, anorexia and low nutrient consumption, uremic toxins, decreased clearance of inflammatory cytokines, quantity overload, and dialysis-related components.
  • MICS is believed to be the primary reason behind erythropoietin hyporesponsiveness, excessive charge of cardiovascular atherosclerotic illness, decreased high quality of life, and elevated mortality and hospitalization in dialysis sufferers.
  • As a result of MICS results in a low physique mass index, hypocholesterolemia, hypocreatininemia, and hypohomocysteinemia, a “reverse epidemiology” of cardiovascular dangers can happen in dialysis sufferers.
  • Due to this fact, weight problems, hypercholesterolemia, and elevated blood ranges of creatinine and homocysteine look like protecting and paradoxically related to a greater end result.
  • There isn’t a consensus about tips on how to decide the diploma of severity of MICS or tips on how to handle it. A number of diagnostic instruments and therapy modalities are mentioned. Profitable administration of MICS might ameliorate the cardiovascular epidemic and poor end result in dialysis sufferers.
  • Scientific trials specializing in MICS and its doable causes and penalties are urgently required to enhance poor medical end result in dialysis sufferers.

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-100ug

QP11732-100ug 100ug
EUR 218

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-1mg

QP11732-1mg 1mg
EUR 1061

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-500ug

QP11732-500ug 500ug
EUR 663

EBNA1 protein

30-1925 500 ug
EUR 565
Description: Purified Recombinant EBNA1 protein

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]

VAng-2528Lsx-100g 100 µg
EUR 463
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]

VAng-2528Lsx-1mg 1 mg
EUR 2800
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]

VAng-2528Lsx-500g 500 µg
EUR 1700
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST]

VAng-Lsx0111-100g 100 µg
EUR 633
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST]

VAng-Lsx0111-500g 500 µg
EUR 2016
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli.

pCXWB- EBNA1

PVT10196 2 ug
EUR 301

Recombinant (E.Coli, GST tag) Epstein-Barr Virus (EBV/HHV-4) Mosaic EBNA1

RP-347 100 ug
EUR 286

Recombinant EBNA1 Protein [GST]

VAng-Lsx0122-100g 100 µg
EUR 682
Description: EBNA1 (EBV) (P03211) partial recombinant protein with GST tag expressed in E. coli.

EBNA1 protein (His tag)

80-1340 100 ug
EUR 241
Description: Purified recombinant EBNA1 protein (His tag)

EBV Protein

abx069822-1ml 1 ml
EUR 690

EBV Protein

abx069824-1mg 1 mg
EUR 1469

EBV Protein

abx069825-1ml 1 ml
EUR 314

EBV Protein

abx069828-1mg 1 mg
EUR 1817

EBV Protein

abx069829-1mg 1 mg
EUR 1776

EBV protein

30-1275 1 mg
EUR 3481
Description: Purified recombinant EBV protein

EBV protein

30-1276 1 mg
EUR 3481
Description: Purified recombinant EBV protein

EBNA1 Binding Protein 2 Protein

20-abx260778
  • EUR 3418.00
  • EUR 328.00
  • EUR 230.00
  • 1 mg
  • 20 ug
  • 5 ug

pCXWB- EBNA1 Plasmid

PVT7175 2 ug
EUR 266

Recombinant EBV Protein

VAng-Lsx0108-inquire inquire Ask for price
Description: EBV, recombinant protein from human cells.

EBV EA protein

30-1280 1 mg
EUR 3481
Description: Purified recombinant EBV EA protein

EBV VCA protein

30-1811 1 ml
EUR 381
Description: Purified native EBV VCA gp125 protein

EBV EA protein

30-1920 1 ml
EUR 414
Description: Viral lysate containing a high concentration of EBV antigens, including VCA, EBNA, EA-D and EA-R

EBV EBNA protein

30-AE46 200 ug
EUR 750
Description: Purified recombinant EBV EBNA protein

EBV EA protein

30-AE50 200 ug
EUR 813
Description: Purified recombinant EBV EA protein

EBV EA protein

30R-AE005 100 ug
EUR 327
Description: Purified recombinant EBV EA protein

EBV p18 protein

30R-AE007 500 ug
EUR 806
Description: Purified recombinant EBV p18 protein

EBV p23 protein

30R-AE008 100 ug
EUR 327
Description: Purified recombinant EBV p23 protein

EBNA1 (GFP-Puro) Lentivirus

LVP1134-GP 1x107 IFU/ml x 200ul
EUR 349
Description: Premade lentivirus expressing Epstein Barr Virus' EBNA1 gene under EF1a promoter, containing GFP-Puromycin dual marker.

EBNA1 (RFP-Bsd) Lentivirus

LVP1134-RB 1x107 IFU/ml x 200ul
EUR 349
Description: Premade lentivirus expressing Epstein Barr Virus' EBNA1 gene under EF1a promoter, containing RFP-Blasticidin dual marker.

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody

20-abx123650
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody

abx026949-400ul 400 ul
EUR 523

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody

abx026949-80l 80 µl
EUR 286

EBV [His]

DAG1578 100 µg
EUR 810

EBV [GST]

DAG1580 100 µg
EUR 645

EBV [GST]

DAG1581 100 µg
EUR 810

EBV [His]

DAG1584 100 µg
EUR 810

EBV Virus

G229 10 ml
EUR 735

EBV antibody

10-E40C 200 ug
EUR 229
Description: Mouse monoclonal EBV antibody

EBV antibody

10-E40D 200 ug
EUR 136
Description: Mouse monoclonal EBV antibody

EBV antibody

10-E40E 200 ug
EUR 212
Description: Mouse monoclonal EBV antibody

EBV P18 Mosaic protein

DAG1582 100 µg
EUR 645

EBV VCA p23 Protein

abx069823-1mg 1 mg
EUR 1497

Recombinant EBV Protein [His]

VAng-Lsx0112-inquire inquire Ask for price
Description: EBV [His], recombinant protein from E. coli.

Recombinant EBV P125 Protein

VAng-Lsx0119-1mL 1 mL
EUR 388
Description: EBV P125 Protein, recombinant protein from E. coli.

Recombinant EBV P125 Protein

VAng-Lsx0119-25mL 25 mL
EUR 6099
Description: EBV P125 Protein, recombinant protein from E. coli.

Epstein-Barr Virus (HHV-4) EBNA1 Protein

20-abx260340
  • EUR 1121.00
  • EUR 467.00
  • EUR 1970.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant EBNA1 Protein [His] (1.185 mg/mL)

VAng-0610Lsx-inquire inquire Ask for price
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.185 mg/mL.

Recombinant EBNA1 Protein [His] (1.25 mg/mL)

VAng-0611Lsx-inquire inquire Ask for price
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.25 mg/mL.

EBNA1BP2 EBNA1 Binding Protein 2 Human Recombinant Protein

PROTQ99848 Regular: 20ug
EUR 317
Description: Recombinant Human EBNA1BP2 produced in E. coli is a single polypeptide chain containing 329 amino acids (1-306) and having a molecular mass of 37.2kDa.;EBNA1BP2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

EBV HHV-4 p23 Protein

abx060518-1mg 1 mg
EUR 1887

EBV p54 (EA-D) Protein

abx061433-1mg 1 mg
EUR 1511

Recombinant EBV P18 Mosaic Protein

VAng-Lsx0115-inquire inquire Ask for price
Description: EBV P18 Mosaic protein, recombinant protein from E. coli.

Recombinant EBV P23 Protein [His]

VAng-Lsx0117-inquire inquire Ask for price
Description: Recombinant EBV p23 protein was expressed in E. coli and purified by proprietary chromatographic technique, 17.7kDa.

Recombinant EBV BFRF3 Protein [GST]

VAng-Lsx0120-inquire inquire Ask for price
Description: BFRF3 (EBV) (P14348) partial recombinant protein with GST tag expressed in E. coli.

Recombinant EBV BMRF1 Protein [GST]

VAng-Lsx0121-inquire inquire Ask for price
Description: BMRF1 (EBV) (P03191) partial recombinant protein with GST tag expressed in E. coli.

Inactivated EBV gp125 VCA Protein

VAng-Lsx04574-1mL 1 mL
EUR 353
Description: Epstein-Barr Virus (Strain P3HR1) gp125 VCA, inactivated antigen.

Inactivated EBV gp125 VCA Protein

VAng-Lsx04574-25mL 25 mL
EUR 6099
Description: Epstein-Barr Virus (Strain P3HR1) gp125 VCA, inactivated antigen.

Recombinant EBV P138 Protein [His]

VAng-0612Lsx-inquire inquire Ask for price
Description: EBV p138 Early Antigen D (EA-D) Protein, recombinant protein from E. coli. 1.00 mg/mL.

Recombinant EBV P54 Protein [His]

VAng-0613Lsx-inquire inquire Ask for price
Description: EBV p54 Early Antigen D (EA-D) Protein, recombinant protein from E. coli. 1.068 mg/mL.

Recombinant EBV P18 Protein [His]

VAng-0614Lsx-inquire inquire Ask for price
Description: EBV Viral Capsid Antigen (VCA) p18, recombinant protein from E. coli. 2.14 mg/mL.

Recombinant EBV p23 Protein [GST]

VAng-0617Lsx-inquire inquire Ask for price
Description: EBV p23, recombinant protein from E. coli. 1.00 mg/mL.

EBV p18 protein (His tag)

80-1355S 100 ug
EUR 241
Description: Purified recombinant EBV p18 protein (His tag)

EBV p54 protein (His tag)

80-1361 1 mg
EUR 1083
Description: Purified recombinant EBV p54 protein (His tag)

EBV p138 protein (His tag)

80-1362 1 mg
EUR 1083
Description: Purified recombinant EBV p138 protein (His tag)

EBV BMRF1 [GST]

DAG1849 500 ug
EUR 2529

EBV Glycoprotein 125

DAG3085 25 ml
EUR 1639

Recombinant EBV p18

DAGA-3074 100ug
EUR 1066

EBV LMP2A Antibody

abx021712-025mg 0.25 mg
EUR 1010

Inactivated EBV Antigen

VAng-Lsx0109-1mL 1 mL
EUR 1360
Description: EBV, natural antigen.

EBV antibody (VCA)

10-E40B 200 ug
EUR 229
Description: Mouse monoclonal EBV antibody (VCA)

Human EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit

abx384822-96tests 96 tests
EUR 911

Mouse EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit

abx389130-96tests 96 tests
EUR 911

Epstein-Barr Virus (HHV-4) Mosaic EBNA1 Protein

20-abx260113
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg